Stryker vs. Johnson & Johnson vs. Zimmer Biomet: How they compare in Q1

Stryker, Johnson & Johnson and Zimmer Biomet all saw first-quarter revenue increases. The devicemakers also saw overall growth in their spine and orthopedic segments year over year.

Advertisement

Here is how their first-quarter performances compare:

Stryker

Total sales: $4.3 billion (+8.1 percent) 

Spine: $279 million (+0.1 percent)

Orthopedic: $1.9 billion (+8.1 percent)

Hips: $327 million (+5.9 percent)

Knees: $464 million (+12.5 percent)

 

Johnson & Johnson

Total sales: $23.4 billion (+5 percent)

Spine, sports and other: $712 million (+0.6 percent)

Orthopedic: $2.2 billion (+3.5 percent)

Hips: $389 million (+9.3 percent)

Knees: $339 million (+6.7 percent)

 

Zimmer Biomet

Total sales: $1.7 billion (+3.9 percent)

Hips: $451 million (+0.9 percent)

Knees: $662.8 million (+7.9 percent)

Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $416.8 million (-0.2 percent)

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.